VERACYTE, INC. cotiza a 45.23 USD y tiene una capitalización bursátil de $3.6B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosign…
| Periodo | 2026-11 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.54 | $0.52 | $0.53 |
| Estimado | $0.41 | $0.43 | $0.33 | $0.41 |
| Sorpresa | — | +25.6% | +57.6% | +29.3% |
| Métrica | VCYT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 70.1% | 57.0% | +13.1% |
| Operating Margin | 11.2% | -38.6% | +49.8% |
| Net Margin | 12.8% | -33.6% | +46.4% |
| FCF Margin | 24.5% | -13.9% | +38.3% |
| ROE | 5.1% | -40.4% | +45.5% |
| ROA | 4.7% | -32.0% | +36.7% |
| Current Ratio | 8.15 | 2.84 | +5.31 |
| Debt / Equity | — | 0.28 | — |